Success Stories: EB1A Approval for a Professor in the field of Psychiatric Research in only 2 days
Client’s Testimonial:
Thanks very much for your help. I will definitely share my good experience with your firm on Linkedin and recommend you to my friends.
On August 14th, 2013 we received another EB1-A (Alien of Extraordinary Ability) Approval for a Professor in the field of Psychiatric Research (Approval Notice)
General Field: Psychiatric Research Position at the Time of Case Filing: Professor Country of Origin: Iran Service Center: Texas Service Center (TSC) Residence at the Time of Filing: Iran Approval Notice Date: August 14, 2013 Processing Time: 2 days (Premium Processing Service requested)
Case Summary:
The client in this case was a professor in the field of psychiatric research. His work had primarily focused on the study of attention deficit hyperactivity disorder (ADHD) and autism through research on their prevalence and their potential treatment options. His work had resulted in at least 204 peer-reviewed scientific articles. At the time that his case was filed, his publications had accumulated at least 1,420 citations, clearly demonstrating that he had influenced his field and garnered international acclaim. In addition, he had had applied his considerable expertise as a peer reviewer for 4 journals related to the field of psychiatric research. Of his accomplishments, one of his independent recommenders remarked, “In summary, I am happy to provide this independent recommendation for [client] as a testament to his excellence in autism research, and to his enormous impacts on the field of autism research which have led to global recognition.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to enter the United States to continue work in the area of extraordinary ability, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in just 2 days.

